Screener
AnaptysBio, Inc. ANAB Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchase of investments | — | (122,547) |
| Sales and maturities of investments | 35,000 | 137,429 |
| Purchases of property and equipment | (17) | (35) |
| Net cash provided by investing activities | 34,983 | 14,847 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from issuance of common stock | 14,021 | 290 |
| Repurchase and retirements of common stock | — | (4,424) |
| Payment for net share settlement of equity awards | — | (1,451) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s investing cash flow?
- AnaptysBio, Inc. (ANAB) reported investing cash flow of $34.98M in Q1 2026.
- How has AnaptysBio, Inc.'s investing cash flow changed year-over-year?
- AnaptysBio, Inc.'s investing cash flow increased by 135.6% year-over-year, from $14.85M to $34.98M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about AnaptysBio, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude